Rankings
▼
Calendar
AXGN Q4 2023 Earnings — AxoGen, Inc. Revenue & Financial Results | Market Cap Arena
AXGN
AxoGen, Inc.
$2B
Q4 2023 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$43M
+18.7% YoY
Gross Profit
$34M
78.7% margin
Operating Income
-$3M
-7.4% margin
Net Income
-$4M
-9.1% margin
EPS (Diluted)
$-0.09
QoQ Revenue Growth
+4.0%
Cash Flow
Operating Cash Flow
-$211,000
Free Cash Flow
-$2M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$197M
Total Liabilities
$101M
Stockholders' Equity
$96M
Cash & Equivalents
$31M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$43M
$36M
+18.7%
Gross Profit
$34M
$30M
+12.5%
Operating Income
-$3M
-$6M
+43.0%
Net Income
-$4M
-$5M
+28.1%
← FY 2023
All Quarters
Q1 2024 →